Browse by Category for Research/Development Jobs at Biotechnology/Pharmaceuticals in New York, New York
| Research Scientist (13) |
Browse by Business for Research/Development Jobs at Biotechnology/Pharmaceuticals in New York, New York
| Biotechnology (13) |
13 Research/Development Jobs found in New York, New York
ImClone Systems|New York, NY, 10095, USA|5
United States State New York City New York Job Type Regular Relocation Work Shift...Category Scientific Country United States State New York City...
ImClone Systems|New York, NY, 10095, USA|1
United States State New York City New York Job Type Regular Relocation Work Shift...Category Scientific Country United States State New York City...
ImClone Systems|New York, NY, 10095, USA|4-5
United States State New York City New York Job Type Regular Relocation Yes Work...Category Scientific Country United States State New York City...
ImClone Systems|New York, NY, 10095, USA|4-5
United States State New York City New York Job Type Regular Relocation Yes Work...Category Scientific Country United States State New York City...
ImClone Systems|New York, NY, 10095, USA|>3
United States State New York City New York Job Type Regular Relocation Yes Work...Category Scientific Country United States State New York City...
ImClone Systems|New York, NY, 10095, USA|>4
United States State New York City New York Job Type Regular Relocation Work Shift...Category Scientific Country United States State New York City...
ImClone Systems|New York, NY, 10095, USA|1
United States State New York City New York Job Type Regular Relocation Work Shift...Category Scientific Country United States State New York City...
ImClone Systems|New York, NY, 10014|4-5
ImClone Systems is dedicated to developing and commercializing novel therapeutic products in the field of oncology. Our efforts have resulted in a commercially available novel therapy, ERBITUX (cetuximab), as well as a broad spectrum of innovative product candidates with potential application in multiple tumor types. As a member of the oncology community, we are committed to providing treatments to meet the unmet needs of cancer patients. To fulfill this commitment, ImClone Systems fosters integration of
ImClone Systems|New York, NY, 10014|1
ImClone Systems is dedicated to developing and commercializing novel therapeutic products in the field of oncology. Our efforts have resulted in a commercially available novel therapy, ERBITUX (cetuximab), as well as a broad spectrum of innovative product candidates with potential application in multiple tumor types. As a member of the oncology community, we are committed to providing treatments to meet the unmet needs of cancer patients. To fulfill this commitment, ImClone Systems fosters integration of
ImClone Systems|New York, NY, 10014|5
ImClone Systems is dedicated to developing and commercializing novel therapeutic products in the field of oncology. Our efforts have resulted in a commercially available novel therapy, ERBITUX (cetuximab), as well as a broad spectrum of innovative product candidates with potential application in multiple tumor types. As a member of the oncology community, we are committed to providing treatments to meet the unmet needs of cancer patients. To fulfill this commitment, ImClone Systems fosters integration of
ImClone Systems|New York, NY, 10014|4-5
ImClone Systems is dedicated to developing and commercializing novel therapeutic products in the field of oncology. Our efforts have resulted in a commercially available novel therapy, ERBITUX (cetuximab), as well as a broad spectrum of innovative product candidates with potential application in multiple tumor types. As a member of the oncology community, we are committed to providing treatments to meet the unmet needs of cancer patients. To fulfill this commitment, ImClone Systems fosters integration of
ImClone Systems|New York, NY, 10014|>3
ImClone Systems is dedicated to developing and commercializing novel therapeutic products in the field of oncology. Our efforts have resulted in a commercially available novel therapy, ERBITUX (cetuximab), as well as a broad spectrum of innovative product candidates with potential application in multiple tumor types. As a member of the oncology community, we are committed to providing treatments to meet the unmet needs of cancer patients. To fulfill this commitment, ImClone Systems fosters integration of
ImClone Systems|New York, NY, 10014|>4
ImClone Systems is dedicated to developing and commercializing novel therapeutic products in the field of oncology. Our efforts have resulted in a commercially available novel therapy, ERBITUX (cetuximab), as well as a broad spectrum of innovative product candidates with potential application in multiple tumor types. As a member of the oncology community, we are committed to providing treatments to meet the unmet needs of cancer patients. To fulfill this commitment, ImClone Systems fosters integration of
Copyright © 2002-2008 Trovix, Inc. Your use of this service and the Trovix Site
is subject to our Terms of Use and Privacy Policy
is subject to our Terms of Use and Privacy Policy